ask="2.10"
ask_size="500"
average_daily_volume="49405"
bid="1.52"
bid_size="1000"
book_value="0.81"
change="+0.14"
change_from_200_day_moving_average="0.28"
change_from_50_day_moving_average="0.32"
change_from_52_week_high="-1.68"
change_From_52_week_low="0.78"
change_in_percent="+7.53%"
close="2.00"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-0.26"
ebitda="-6.98M"
eps_estimate_current_year="-0.16"
eps_estimate_next_quarter="0.00"
eps_estimate_next_year="-0.48"
ex_dividend_date="N/A"
float_shares="2843000"
high="2.05"
high_52_weeks="3.68"
last_trade_date="2/17/2017"
last_trade_price="2.00"
last_trade_size="100"
last_trade_time="3:54pm"
low="1.87"
low_52_weeks="1.22"
market_capitalization="21.97M"
moving_average_200_day="1.72"
moving_average_50_day="1.68"
name="Cleveland BioLabs
Inc."
notes="N/A"
one_year_target_price="2.00"
open="1.87"
pe_ratio="N/A"
peg_ratio="0.00"
percent_change_from_200_day_moving_average="+15.96%"
percent_change_from_50_day_moving_average="+19.38%"
percent_change_from_52_week_high="-45.65%"
percent_change_from_52_week_low="+63.93%"
previous_close="1.86"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="2.29"
price_per_sales="5.38"
revenue="3.80M"
shares_outstanding="10987000"
short_ratio="0.62"
stock_exchange="NCM"
symbol="CBLI"
volume="127869"
weeks_range_52="1.22 - 3.68"
